Interventional cardiology devices are primarily related to heart disease , and most of the heart diseases have some serious medical conditions , such as angina , congestive heart failure , and arrhythmias . These are often caused by partially blocked coronary arteries , which is the most common cause of death globally . Since the 1980s , balloon angioplasty has been the standard method for treating coronary artery disease . Coronary artery disease ( CAD ) blocks the artery that supplies blood to the heart . It occurs when the coronary artery is narrowed or blocked with the formation of plaque , which forms due to reasons such as cholesterol , fatty deposits , calcium , and other substances .
The report covers the present scenario and the growth prospects of the global interventional cardiology market for 2017-2021 . To calculate the market size , the report considers the revenue generated from the sales of interventional cardiovascular devices to key end-users such as hospitals and ambulatory surgical centers ( ASCs ).
The market is divided into the following segments based on geography : Americas APAC EMEA
Global Interventional Cardiology Market 2017-2021 , has been prepared based on an in-depth market analysis with inputs from industry experts . The report covers the market landscape and its growth prospects over the coming years . The report also includes a discussion of the key vendors operating in this market .
Key vendors Abbott Vascular Boston Scientific Cordis Medtronic St . Jude Medical